Business
Oriental Rise Receives Nasdaq Staff Delisting Determination
NINGDE, China, April 20, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (NASDAQ: ORIS) (“Oriental Rise” or the “Company”), an integrated tea supplier in mainland China, today announced that it received a staff determination letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 15, 2026, notifying the Company that Nasdaq has determined to delist the Company’s ordinary shares from The Nasdaq Capital Market. Accord
About this update from Oriental Rise Holdings Limited
[{"type":"text","content":"NINGDE, China, April 20, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (NASDAQ: ORIS) (“Oriental Rise” or the “Company”), an integrated tea supplier in mainland China, today announced that it received a staff determination letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 15, 2026, notifying the Company that Nasdaq has determined to delist the Company’s ordinary shares from The Nasdaq Capital Market.","length":494,"tagName":"p"},{"type":"text","content":"According to the Determination Letter, Nasdaq determined that the closing bid price of the Company’s listed securities had been below $1.00 per share for the previous 30 consecutive business days and that the Company therefore no longer complies with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.","length":367,"tagName":"p"},{"type":"text","content":"Nasdaq further stated that, because the Company effected a 1-for-20 reverse stock split on December 30, 2025, the Company is not eligible for the 180-calendar day compliance period that would otherwise be available under Nasdaq Listing Rule 5810(c)(3)(A).","length":255,"tagName":"p"},{"type":"text","content":"Nasdaq has advised the Company that, unless the Company requests a hearing before a Nasdaq Hearings Panel by April 22, 2026, trading in the Company’s ordinary shares will be suspended at the opening of business on April 24, 2026, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to remove the Company’s securities from listing and registration on The Nasdaq Stock Market.","length":406,"tagName":"p"},{"type":"text","content":"The Company intends to timely request a hearing before the Nasdaq Hearings Panel. The hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. The Company is currently evaluating its options and intends to present a plan to regain compliance with Nasdaq’s continued listing requirements.","length":363,"tagName":"p"},{"type":"text","content":"There can be no assurance that the Hearings Panel will grant the Company’s request for continued listing or that the Company will be able to regain compliance with the applicable continued listing requireme...